|
REGN7508 Clinical Trials
4 actively recruiting trials across 2 locations
▲ +1 trial since May 2026
Also known as: cenvacibart
Pipeline
Phase 2: 1Phase 3: 3
Top Sponsors
- Regeneron Pharmaceuticals4
Indications
- Atrial Fibrillation (AF)2
- Heart Disease2
- Lung Cancer2
- Cancer2
- Cancer-Associated Thrombosis (CAT)1
Dothan, Alabama2 trials
Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
SEC Clinical Research
Phase 2
Hialeah, Florida2 trials
REGN7508 in Adult Participants for Prevention of Cancer-Associated Thrombosis
Bioresearch Partner- Hialeah Hospital
Phase 3
Treatment and Secondary Prevention of Venous Thromboembolism (VTE) in Adult Participants With Solid and Hematologic Cancers
Bioresearch Partner- Hialeah Hospital
Phase 3
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.